257 related articles for article (PubMed ID: 12682789)
1. Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms.
Pfannenberg AC; Eschmann SM; Horger M; Lamberts R; Vonthein R; Claussen CD; Bares R
Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):835-43. PubMed ID: 12682789
[TBL] [Abstract][Full Text] [Related]
2. Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours.
Gabriel M; Hausler F; Bale R; Moncayo R; Decristoforo C; Kovacs P; Virgolini I
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1440-51. PubMed ID: 16133384
[TBL] [Abstract][Full Text] [Related]
3. Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors.
Perri M; Erba P; Volterrani D; Lazzeri E; Boni G; Grosso M; Mariani G
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):323-33. PubMed ID: 18480741
[TBL] [Abstract][Full Text] [Related]
4. Value of SPET/CT image fusion in the assessment of neuroendocrine tumours with 111In-pentetreotide scintigraphy.
Moreira AP; Duarte LH; Vieira F; João F; Lima JP
Rev Esp Med Nucl; 2005; 24(1):14-8. PubMed ID: 15701341
[TBL] [Abstract][Full Text] [Related]
5. SPET/CT image co-registration in the abdomen with a simple and cost-effective tool.
Förster GJ; Laumann C; Nickel O; Kann P; Rieker O; Bartenstein P
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):32-9. PubMed ID: 12483407
[TBL] [Abstract][Full Text] [Related]
6. (111)In-pentetreotide SPET/CT in carcinoid tumours: is the role of hybrid systems advantageous in abdominal or thoracic lesions?
Tranfaglia C; Cardinali L; Gattucci M; Scialpi M; Ferolla P; Sinzinger H; Palumbo B
Hell J Nucl Med; 2011; 14(3):274-7. PubMed ID: 22087449
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound.
Ji T; Sun Y; Chen B; Ji B; Gao S; Ma Q; Cheng G; Zhang H
Hell J Nucl Med; 2015; 18(2):108-13. PubMed ID: 26187209
[TBL] [Abstract][Full Text] [Related]
8. Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography?
Chajari M; Lacroix J; Peny AM; Chesnay E; Batalla A; Henry-Amar M; Delcambre C; Génot JY; Fruchard C; Bardet S
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):380-7. PubMed ID: 12002715
[TBL] [Abstract][Full Text] [Related]
9. Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours.
Castaldi P; Rufini V; Treglia G; Bruno I; Perotti G; Stifano G; Barbaro B; Giordano A
Radiol Med; 2008 Oct; 113(7):1056-67. PubMed ID: 18797822
[TBL] [Abstract][Full Text] [Related]
10. Incremental value of
Trogrlic M; Težak S
Nuklearmedizin; 2017 Jun; 56(3):97-107. PubMed ID: 28164207
[TBL] [Abstract][Full Text] [Related]
11. The value of SPET/CT in chronic osteomyelitis.
Horger M; Eschmann SM; Pfannenberg C; Storek D; Dammann F; Vonthein R; Claussen CD; Bares R
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1665-73. PubMed ID: 14523585
[TBL] [Abstract][Full Text] [Related]
12. Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours.
Amthauer H; Denecke T; Rohlfing T; Ruf J; Böhmig M; Gutberlet M; Plöckinger U; Felix R; Lemke AJ
Eur Radiol; 2005 Jul; 15(7):1456-62. PubMed ID: 15627182
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
Etchebehere EC; de Oliveira Santos A; Gumz B; Vicente A; Hoff PG; Corradi G; Ichiki WA; de Almeida Filho JG; Cantoni S; Camargo EE; Costa FP
J Nucl Med; 2014 Oct; 55(10):1598-604. PubMed ID: 25168627
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions.
Zhang Y; Shi H; Gu Y; Xiu Y; Li B; Zhu W; Chen S; Yu H
Nucl Med Commun; 2011 Dec; 32(12):1194-200. PubMed ID: 21934544
[TBL] [Abstract][Full Text] [Related]
16. Contribution of ¹¹¹In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours.
Sainz-Esteban A; Olmos R; González-Sagrado M; González ML; Ruiz MÁ; García-Talavera P; Gamazo C; Villanueva JG; Cobo A; de Luis D
Nucl Med Commun; 2015 Mar; 36(3):251-9. PubMed ID: 25369750
[TBL] [Abstract][Full Text] [Related]
17. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis.
Ingui CJ; Shah NP; Oates ME
Clin Nucl Med; 2006 Nov; 31(11):665-72. PubMed ID: 17053381
[TBL] [Abstract][Full Text] [Related]
18. Attenuation correction of somatostatin receptor SPECT by integrated low-dose CT: is there an impact on sensitivity?
Steffen IG; Mehl S; Heuck F; Elgeti F; Furth C; Amthauer H; Ruf J
Clin Nucl Med; 2009 Dec; 34(12):869-73. PubMed ID: 20139819
[TBL] [Abstract][Full Text] [Related]
19. Added value of SPECT/CT in patients suspected of having bone infection: preliminary results.
Horger M; Eschmann SM; Pfannenberg C; Storek D; Vonthein R; Claussen CD; Bares R
Arch Orthop Trauma Surg; 2007 Apr; 127(3):211-21. PubMed ID: 17146681
[TBL] [Abstract][Full Text] [Related]
20. Prediction of clinical outcome in treated neuroendocrine tumours of carcinoid type using functional volumes on 111In-pentetreotide SPECT imaging.
Gopinath G; Ahmed A; Buscombe JR; Dickson JC; Caplin ME; Hilson AJ
Nucl Med Commun; 2004 Mar; 25(3):253-7. PubMed ID: 15094443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
